Ampio Pharmaceuticals announces financing transaction of $25 million Ampio Pharmaceuticals.

The closing of the authorized direct placement of the normal stock of the Company is expected to take place on or around September 30, 2013, subject to fulfillment of customary closing conditions.. Ampio Pharmaceuticals announces financing transaction of $25 million Ampio Pharmaceuticals, Inc. today announced a financing deal that will provide $25 million in gross proceeds to the Company. The Company has entered into a definitive agreement with a restricted number of purchasers, mainly institutional investors, regarding the the registered direct placement of common share of the ongoing business, in which the investors have decided to purchase an aggregate of 4,600,319 shares of common stock of the Company pursuant to the Firm's effective sign up statement at an offering cost of $5.50 per share, for a total of $25 million of gross proceeds.Ehrlichia chaffeensis impacts people and animals mainly in the southeastern and south central parts of the U.S. It really is transmitted by the lone superstar tick. The resulting sickness, termed Ehrlichiosis, is normally hard to diagnose because its symptoms’ similarities with various other, more minor infections. Medical indications include headache, fever, muscle and malaise aches. For all those with compromised immune systems, the infection could possibly be fatal. Though hardly any situations are reported – – around 1,500 because the Centers for Disease Control considered it an illness of concern in the past due 1980s – – Ganta estimates that as much as 50,000 folks have contracted ehrlichia chaffeensis actually.